Chemo May Cost Breast Cancer Survivors 9.4 Years
Chemo May Cost Breast Cancer Survivors 9.4 Years
Chemo May Cost Breast Cancer Survivors 9.4 Years
Key points
اہم نکات
मुख्य बातें
- Chemotherapy for breast cancer may cost survivors 9.4 years of life, as a new study finds the treatment speeds up biological aging long after the cancer is gone.
- Researchers at Georgetown University's Lombardi Comprehensive Cancer Center, writing in JAMA Network Open on November 10, estimated that the most toxic chemotherapy regimens cut 9.4 years from a survivor's remaining life through earlier aging-related disease.
- Anthracycline-based regimens cost a median 7.6 years more than gentler treatments.
- Chemotherapy for breast cancer may cost survivors 9.4 years of life, as a new study finds the treatment speeds up biological aging long after the cancer is gone.
- Researchers at Georgetown University's Lombardi Comprehensive Cancer Center, writing in JAMA Network Open on November 10, estimated that the most toxic chemotherapy regimens cut 9.4 years from a survivor's remaining life through earlier aging-related disease.
- Anthracycline-based regimens cost a median 7.6 years more than gentler treatments.
- Chemotherapy for breast cancer may cost survivors 9.4 years of life, as a new study finds the treatment speeds up biological aging long after the cancer is gone.
- Researchers at Georgetown University's Lombardi Comprehensive Cancer Center, writing in JAMA Network Open on November 10, estimated that the most toxic chemotherapy regimens cut 9.4 years from a survivor's remaining life through earlier aging-related disease.
- Anthracycline-based regimens cost a median 7.6 years more than gentler treatments.
Chemotherapy for breast cancer may cost survivors 9.4 years of life, as a new study finds the treatment speeds up biological aging long after the cancer is gone. Researchers at Georgetown University's Lombardi Comprehensive Cancer Center, writing in JAMA Network Open on November 10, estimated that the most toxic chemotherapy regimens cut 9.4 years from a survivor's remaining life through earlier aging-related disease. Anthracycline-based regimens cost a median 7.6 years more than gentler treatments. The team says the findings point to a need for treatments that slow or reverse aging after cancer, so survivors keep more healthy years.
Chemotherapy for breast cancer may cost survivors 9.4 years of life, as a new study finds the treatment speeds up biological aging long after the cancer is gone. Researchers at Georgetown University's Lombardi Comprehensive Cancer Center, writing in JAMA Network Open on November 10, estimated that the most toxic chemotherapy regimens cut 9.4 years from a survivor's remaining life through earlier aging-related disease. Anthracycline-based regimens cost a median 7.6 years more than gentler treatments. The team says the findings point to a need for treatments that slow or reverse aging after cancer, so survivors keep more healthy years.
Chemotherapy for breast cancer may cost survivors 9.4 years of life, as a new study finds the treatment speeds up biological aging long after the cancer is gone. Researchers at Georgetown University's Lombardi Comprehensive Cancer Center, writing in JAMA Network Open on November 10, estimated that the most toxic chemotherapy regimens cut 9.4 years from a survivor's remaining life through earlier aging-related disease. Anthracycline-based regimens cost a median 7.6 years more than gentler treatments. The team says the findings point to a need for treatments that slow or reverse aging after cancer, so survivors keep more healthy years.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।